NCT06162247 Naples Federico II Intensive Cardiac Care Unit Registry (Naples FED2-ICCU Registry)
| NCT ID | NCT06162247 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Federico II University |
| Condition | Acute Cardiovascular Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2023-11-20 |
| Primary Completion | 2033-11-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2023-11-20 with a primary completion date of 2033-11-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This protocol proposes to prospectively evaluate current epidemiology, pharmacologic and invasive management and clinical outcomes of patients with acute cardiovascular diseases admitted at our ICCU.
Eligibility Criteria
Inclusion Criteria: 1. Acute cardiovascular disease admitted at our ICCU 2. Age ≥18 years; 3. Written informed consent. Exclusion Criteria: 1\) Patients not providing consent to data collection
Contact & Investigator
Giuseppe Gargiulo, MD, PhD
PRINCIPAL INVESTIGATOR
Department of Advanced Biomedical Sciences
Frequently Asked Questions
Who can join the NCT06162247 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Cardiovascular Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06162247 currently recruiting?
Yes, NCT06162247 is actively recruiting participants. Contact the research team at giuseppe.gargiulo1@unina.it for enrollment information.
Where is the NCT06162247 trial being conducted?
This trial is being conducted at Naples, Italy.
Who is sponsoring the NCT06162247 clinical trial?
NCT06162247 is sponsored by Federico II University. The principal investigator is Giuseppe Gargiulo, MD, PhD at Department of Advanced Biomedical Sciences. The trial plans to enroll 5,000 participants.